Income Taxes	3 Months Ended
Mar. 31, 2017
Income Taxes
Income Taxes	Note 8. Income Taxes The Company recognized an income tax expense of $1.0 million and income tax benefit of $1.0 million for the three months ended March 31, 2017 and 2016, respectively, which was computed using the “discrete” (or “cut-off”) method. The income tax expense and income tax benefit for the three months ended March 31, 2017 and March 31, 2016 was primarily comprised of the intraperiod tax allocation of the deferred tax impact for available-for-sale marketable securities and foreign income tax expense. Based on all available objective evidence, the Company believes that it is still more likely than not that its net deferred tax assets will not be fully realized. Accordingly, the Company maintains a valuation allowance against all of its net deferred tax assets as of both March 31, 2017 and December 31, 2016. The Company will continue to maintain a full valuation allowance until there is sufficient evidence to support recoverability of its deferred tax assets. The Company had $2.2 million and $2.1 million of unrecognized tax benefits at March 31, 2017 and December 31, 2016, respectively. The Company does not anticipate a material change to its unrecognized tax benefits over the next 12 months that would affect its effective tax rate. Unrecognized tax benefits may change during the next 12 months for items that arise in the ordinary course of business. Accrued interest and penalties related to unrecognized tax benefits are recognized as part of the Company’s income tax provision in its condensed consolidated statements of operations. The statute of limitations remain open for the years 2001 through 2017 in U.S. federal and state jurisdictions, and for the years 2011 through 2017 in foreign jurisdictions.

Income Taxes

3 Months Ended

Mar. 31, 2017

Note 8. Income Taxes

The Company recognized an income tax expense of $1.0 million and income tax benefit of $1.0 million for the three months ended March 31, 2017 and 2016, respectively, which was computed using the “discrete” (or “cut-off”) method. The income tax expense and income tax benefit for the three months ended March 31, 2017 and March 31, 2016 was primarily comprised of the intraperiod tax allocation of the deferred tax impact for available-for-sale marketable securities and foreign income tax expense.

Based on all available objective evidence, the Company believes that it is still more likely than not that its net deferred tax assets will not be fully realized. Accordingly, the Company maintains a valuation allowance against all of its net deferred tax assets as of both March 31, 2017 and December 31, 2016. The Company will continue to maintain a full valuation allowance until there is sufficient evidence to support recoverability of its deferred tax assets.

The Company had $2.2 million and $2.1 million of unrecognized tax benefits at March 31, 2017 and December 31, 2016, respectively. The Company does not anticipate a material change to its unrecognized tax benefits over the next 12 months that would affect its effective tax rate. Unrecognized tax benefits may change during the next 12 months for items that arise in the ordinary course of business.

Accrued interest and penalties related to unrecognized tax benefits are recognized as part of the Company’s income tax provision in its condensed consolidated statements of operations. The statute of limitations remain open for the years 2001 through 2017 in U.S. federal and state jurisdictions, and for the years 2011 through 2017 in foreign jurisdictions.